Riitta P. Lassila

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 169 publications

Therapeutic Strategies Combining Antiplatelet With Anticoagulant Actions: Heparin Proteoglycan Mimetic APAC as a Model.

Therapeutic Strategies Combining Antiplatelet With Anticoagulant Actions: Heparin Proteoglycan Mimetic APAC as a Model.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 28, 2026

Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival.

Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 24, 2026

Von Willebrand disease: A century of progress.

Von Willebrand disease: A century of progress.

Journal: Research and practice in thrombosis and haemostasis

Published: February 23, 2026

Seventh Åland Island Meeting on von Willebrand Disease.

Seventh Åland Island Meeting on von Willebrand Disease.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 26, 2026

The landmark contribution by Erik von Willebrand.

The landmark contribution by Erik von Willebrand.

Journal: Haematologica

Published: January 01, 2026

Advances in Von Willebrand Disease.

Advances in Von Willebrand Disease.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 13, 2025

Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma.

Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma.

Journal: Cancer medicine

Published: November 10, 2025

Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned.

Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned.

Journal: Thrombosis research

Published: August 13, 2025

Genetic association of preeclampsia to von Willebrand factor and its size-regulator ADAMTS13.

Genetic association of preeclampsia to von Willebrand factor and its size-regulator ADAMTS13.

Journal: Research square

Published: July 17, 2025

Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells.

Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells.

Journal: Blood vessels, thrombosis & hemostasis

Published: July 11, 2025

A novel p.C1130S mutation in a Finnish family with a complex phenotype of von Willebrand disease.

A novel p.C1130S mutation in a Finnish family with a complex phenotype of von Willebrand disease.

Journal: Haematologica

Published: May 07, 2025

Antithrombotic therapy in patients with inherited bleeding disorders: practical considerations.

Antithrombotic therapy in patients with inherited bleeding disorders: practical considerations.

Journal: Polish archives of internal medicine

Published: April 08, 2025

Showing 1-12 of 169

Last Updated: 09/26/2026